Positive effect of abdominal breathing exercise on gastroesophageal reflux disease: A randomized, controlled study

American Journal of Gastroenterology

Volumn 107, Issue 3, 2012, Pages 372-378

  Eherer, A J ^a   Netolitzky, F ^a   Hogenauer C ^a   Puschnig, G ^a   Hinterleitner, T A ^a   Scheidl, S ^a   Kraxner, W ^a   Krejs, G J ^a   Hoffmann, Karl Martin ^a  

^a MEDICAL UNIVERSITY OF GRAZ   (Austria)

Author keywords

[No Author keywords available]

Indexed keywords

PROTON PUMP INHIBITOR;

ADULT; ARTICLE; BREATHING EXERCISE; CLINICAL ARTICLE; CONTROLLED STUDY; DIAPHRAGM; DIAPHRAGM MUSCLE; ESOPHAGITIS; FEMALE; FOLLOW UP; GASTROESOPHAGEAL REFLUX; HERNIA; HUMAN; LIFESTYLE MODIFICATION; LOWER ESOPHAGUS SPHINCTER; MALE; MANOMETRY; PRIORITY JOURNAL; QUALITY OF LIFE; RANDOMIZED CONTROLLED TRIAL; STOMACH CONTENT; STOMACH PH;

ADULT; BREATHING EXERCISES; ENDOSCOPY, GASTROINTESTINAL; ESOPHAGEAL PH MONITORING; EXERCISE THERAPY; FEMALE; GASTROESOPHAGEAL REFLUX; HUMANS; MALE; MANOMETRY; MIDDLE AGED; PROSPECTIVE STUDIES; PROTON PUMP INHIBITORS; QUALITY OF LIFE; TREATMENT OUTCOME;

EID: 84857919421     PISSN: 00029270     EISSN: 15720241     Source Type: Journal    
DOI: 10.1038/ajg.2011.420     Document Type: Article

References (16)

1. Kahrilas PJ. Clinical practice. Gastroesophageal reflux disease. N Engl J Med 2008; 359: 1700-7.
2. Modlin IM, Hunt RH, Malfertheiner P et al. Diagnosis and management of non-erosive reflux disease-the Vevey NERD Consensus Group. Digestion 2009; 80: 74-88.
3. Jensen RT. Consequences of long-term proton pump blockade: insights from studies of patients with gastrinomas. Basic Clin Pharmacol Toxicol 2006; 98: 4-19.
4. Spechler SJ. Medical or invasive therapy for GERD: an acidulous analysis. Clin Gastroenterol Hepatol 2003; 1: 81-8. (Pubitemid 37248078)
5. Chen D, Barber C, McLoughlin P et al. Systematic review of endoscopic treatments for gastro-oesophageal reflux disease. Br J Surg 2009; 96: 128-36.
6. Kaltenbach T, Crockett S, Gerson LB. Are lifestyle measures effective in patients with gastroesophageal reflux disease? An evidence-based approach. Arch Intern Med 2006; 166: 965-71.
7. Kahrilas PJ, Shaheen NJ, Vaezi MF et al. American Gastroenterological Association Medical Position Statement on the management of gastroesophageal reflux disease. Gastroenterology 2008; 135: 1383-91, 1391.e1-5.
8. Mittal RK, Balaban DH. The esophagogastric junction. N Engl J Med 1997; 336: 924-32. (Pubitemid 27137194)
9. Klein WA, Parkman HP, Dempsey DT et al. Sphincterlike thoracoabdominal high pressure zone aft er esophagogastrectomy. Gastroenterology 1993; 105: 1362-9. (Pubitemid 23315310)
10. Holloway RH, Penagini R, Ireland AC. Criteria for objective definition of transient lower esophageal sphincter relaxation. Am J Physiol 1995; 268 (1 Pt 1): G128-33.
11. Velanovich V. The development of the GERD-HRQL symptom severity instrument. Dis Esophagus 2007; 20: 130-4. (Pubitemid 46562851)
12. Eypasch E, Williams JI, Wood-Dauphinee S et al. Gastrointestinal Quality of Life Index: development, validation and application of a new instrument. Br J Surg 1995; 82: 216-22.
13. Kjellin A, Ramel S, Rossner S et al. Gastroesophageal reflux in obese patients is not reduced by weight reduction. Scand J Gastroenterol 1996; 31: 1047-51. (Pubitemid 26373931)
14. Pandolfino JE, Kwiatek MA, Kahrilas PJ. The pathophysiologic basis for epidemiologic trends in gastroesophageal reflux disease. Gastroenterol Clin North Am 2008; 37: 827-43, viii.
15. Brasseur JG, Ulerich R, Dai Q et al. Pharmacological dissection of the human gastro-oesophageal segment into three sphincteric components. J Physiol 2007; 580 (Pt. 3): 961-75. (Pubitemid 46909045)
16. Miller L, Dai Q, Vegesna A et al. A missing sphincteric component of the gastro-oesophageal junction in patients with GORD. Neurogastroenterol Motil 2009; 21: 813-e52.